* Receives notice of allowance for new patent covering
MN-001 and MN-002 for treatment of Fibrosis
The post BRIEF-Medicinova receives notice of allowance for new patent covering MN-001 and MN-002 for treatment of Fibrosis appeared first on NASDAQ.
BRIEF-Medicinova receives notice of allowance for new patent covering MN-001 and MN-002 for treatment of Fibrosis
